Clinical trial
Eszopiclone in the Treatment of Insomnia and Fibromyalgia
NCT00392041 · Lesley A. Allen, Ph.D., Other · Completed
Key facts
| NCT number | NCT00392041 |
|---|---|
| Title | Eszopiclone in the Treatment of Insomnia and Fibromyalgia |
| Official title | Eszopiclone in the Treatment of Insomnia and Associated Symptoms of Fibromyalgia |
| Lead sponsor | Lesley A. Allen, Ph.D., Other |
| Collaborators | Sumitomo Pharma America, Inc. Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Fibromyalgia, Insomnia |
| Intervention type | Drug |
| Interventions | Eszopiclone, placebo |
| Enrollment | 36 |
| Start date | Aug 1, 2006 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Oct 25, 2006 |
| Last update posted | Jan 5, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: